32
Participants
Start Date
October 2, 2023
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2032
Degarelix
initial dose is 240 mg administered as two 120 mg (3 mL) injections (SC), followed by subsequent doses at 80 mg (4 mL) administered as one injection (SC)
Gemcitabine/Cisplatin
"SOC Neoadjuvant Chemotherapy: Gemcitabine/Cisplatin 21-day cycles (4 cycles total)~* Gemcitabine: 1000 mg/m2 (IV) Days 1 and 8 of each cycle~* Cisplatin: 70 mg/m2 (if borderline renal function: 35 mg/m2) (IV) Day 1 of each cycle (if borderline renal function, days 1 and 8 of each cycle)."
RECRUITING
Lifespan Cancer Institute, Providence
Lead Sponsor
Legorreta Cancer Center at Brown University
UNKNOWN
Lifespan
OTHER
Cures Within Reach
OTHER
Brown University
OTHER